Skip to main content
Watch Insiders

Corporate insider profile

Houte Hans van Insider Trades

Latest reported as Chief Financial Officer of Nurix Therapeutics, Inc. (NRIX).

Purchase filings
0
Reported companies
1
Net open-market value
-$455,581.05
Latest transaction
Aug 4, 2026

Affiliated corporations

Reported company relationships

NRIXLatest reported

Nurix Therapeutics, Inc.

Chief Financial Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 4, 2026Nurix Therapeutics, Inc. (NRIX)Chief Financial OfficerSale4,761$24.36$115,989
Jul 30, 2026Nurix Therapeutics, Inc. (NRIX)Chief Financial OfficerSale2,845$23.38$66,524
May 5, 2026Nurix Therapeutics, Inc. (NRIX)Chief Financial OfficerSale14,055$16.60$233,319
Apr 30, 2026Nurix Therapeutics, Inc. (NRIX)Chief Financial OfficerSale2,388$16.65$39,749